Literature DB >> 16531538

Risk of lymphoma: inflammatory bowel disease and immunomodulators.

Y S Ang, R J Farrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16531538      PMCID： PMC1856179     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.

Authors:  R J Farrell; Y Ang; P Kileen; D S O'Briain; D Kelleher; P W Keeling; D G Weir
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  Limitations of the application of fourfold table analysis to hospital data.

Authors:  J BERKSON
Journal:  Biometrics       Date:  1946-06       Impact factor: 2.571

3.  Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study.

Authors:  E Baecklund; A Ekbom; P Sparén; N Feltelius; L Klareskog
Journal:  BMJ       Date:  1998-07-18

4.  Cancer risk in patients with inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; E Kliewer; A Wajda
Journal:  Cancer       Date:  2001-02-15       Impact factor: 6.860

5.  Increased risk of cancer in ulcerative colitis: a population-based cohort study.

Authors:  P Karlén; R Löfberg; O Broström; C E Leijonmarck; G Hellers; P G Persson
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

6.  Hodgkin's disease risk is increased in patients with ulcerative colitis.

Authors:  D Palli; G Trallori; S Bagnoli; C Saieva; O Tarantino; M Ceroti; G d'Albasio; F Pacini; A Amorosi; G Masala
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

7.  Inflammatory bowel disease is not associated with an increased risk of lymphoma.

Authors:  J D Lewis; W B Bilker; C Brensinger; J J Deren; D J Vaughn; B L Strom
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

8.  Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.

Authors:  L J Kinlen
Journal:  Am J Med       Date:  1985-01-21       Impact factor: 4.965
  8 in total
  1 in total

1.  Progress in the diagnosis and treatment of inflammatory bowel disease.

Authors:  Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.